{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:46:37Z","timestamp":1782823597926,"version":"3.54.5"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Neonatal pneumonia and bronchopulmonary dysplasia (BPD) are major causes of morbidity and mortality in preterm infants, driven by excessive inflammation involving the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome. This study employed\n                      <jats:italic>in silico<\/jats:italic>\n                      drug discovery, including virtual screening, molecular docking, ADMET profiling, molecular dynamics (MD) simulations, and MM\/PBSA calculations, followed by preliminary\n                      <jats:italic>in vitro<\/jats:italic>\n                      validation to identify novel NLRP3 inhibitors from Traditional Chinese Medicine (TCM) compounds for these conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The NLRP3 NACHT domain (PDB ID: 7ALV) served as the target. A library of FDA-approved drugs and TCM-derived compounds underwent molecular docking with AutoDock Vina. Top hits were evaluated for ADMET properties using SwissADME, pkCSM, and admetSAR. Selected complexes (Hinokiflavone, Theaflavin, Sciadopitysin, Liquiritin apioside, Tigogenin) were subjected to 200 ns all-atom MD simulations in GROMACS and MM\/PBSA binding free energy analysis.\n                      <jats:italic>In vitro<\/jats:italic>\n                      cytoprotective effects were assessed via MTT assay in LPS-stimulated BEAS-2B and MLE-12 lung epithelial cells, with glyburide as positive control.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hinokiflavone and Theaflavin exhibited the strongest docking scores (\u221210.8 and \u221210.4\u00a0kcal\/mol), superior MD stability (lowest RMSD: 0.21 \u00b1 0.02 nm and 0.23 \u00b1 0.03 nm; high hydrogen bond occupancy: 78% and 82%), and most favorable MM\/PBSA binding energies (\u221255.8 and \u221255.2\u00a0kcal\/mol), driven by van der Waals and electrostatic interactions. They showed acceptable ADMET profiles with high intestinal absorption and low BBB penetration.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , Hinokiflavone restored cell viability to 89.6% \u00b1 3.2% at 50\u00a0\u00b5M (comparable to glyburide at 91.2% \u00b1 2.8%), while Theaflavin reached 82.4% \u00b1 3.9%, demonstrating dose-dependent protection against LPS-induced cytotoxicity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hinokiflavone and Theaflavin emerge as promising NLRP3 inhibitors with stable binding to the NACHT domain and cytoprotective effects in lung epithelial cells. These TCM-derived compounds warrant further preclinical investigation as potential targeted therapies to mitigate inflammation in neonatal pneumonia and BPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fchem.2026.1859262","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:15:26Z","timestamp":1782821726000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico drug discovery and molecular dynamics simulation for targeting neonatal pneumonia and bronchopulmonary dysplasia"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaoqin","family":"Chen","sequence":"first","affiliation":[{"name":"Xinxiang Central Hospital (Henan Medical University Fourth Clinical College), Neonatal Intensive Care Unit","place":["Xinxiang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Xinxiang Central Hospital (Henan Medical University Fourth Clinical College), Neonatal Intensive Care Unit","place":["Xinxiang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xinxiang Central Hospital (Henan Medical University Fourth Clinical College), Neonatal Intensive Care Unit","place":["Xinxiang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"107691","DOI":"10.1016\/j.micpath.2025.107691","article-title":"Decoding virulence and resistance in klebsiella pneumoniae: pharmacological insights, immunological dynamics, and in silico therapeutic strategies","volume":"205","author":"Alishvandi","year":"2025","journal-title":"Microb. Pathog."},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13721-025-00674-3","article-title":"In silico design of a multi-epitope vaccine against NSCLC targeting T-cell exhaustion and metastasis: insights from RNA-Seq and molecular dynamics simulation analysis","volume":"15","author":"Alishvandi","year":"2026","journal-title":"Netw. Model. Analysis Health Inf. Bioinforma."},{"key":"B4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1152\/physrev.00042.2024","article-title":"The evolving pathophysiology of bronchopulmonary dysplasia","volume":"106","author":"Ambalavanan","year":"2026","journal-title":"Physiol. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101745","DOI":"10.1016\/j.bbrep.2024.101745","article-title":"Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches","volume":"39","author":"Aram","year":"2024","journal-title":"Biochem. Biophysics Rep."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11421-1","article-title":"Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point","author":"Aram","year":"","journal-title":"Mol. Divers."},{"key":"B7","doi-asserted-by":"publisher","first-page":"22610","DOI":"10.1038\/s41598-025-07433-4","article-title":"Development of a candidate mRNA vaccine based on multi-peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach","volume":"15","author":"Aram","year":"","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"100574","DOI":"10.1016\/j.obmed.2024.100574","article-title":"Comparative analysis of fennel essential oil and manganese in PCOS rat model via modulating miR-145 expression and structure-based virtual screening of IGF2R protein to address insulin resistance and obesity","volume":"53","author":"Barancheshmeh","year":"2025","journal-title":"Obes. Med."},{"key":"B9","volume-title":"Prenatal, Perinatal, and Hematological Predictors of Severe Respiratory Failure in Neonatal Pneumonia: A Retrospective Cohort Study","author":"Bui-Binh-Bao","year":"2025"},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/pharmaceutics15010049","article-title":"A guide to in silico drug design","volume":"15","author":"Chang","year":"2022","journal-title":"Pharmaceutics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2000","DOI":"10.1016\/s2214-109x(25)00374-2","article-title":"The pneumonia challenge: time to end the global neglect","volume":"13","author":"Cill\u00f3niz","year":"2025","journal-title":"Lancet Glob. Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.3390\/jcm12134207","article-title":"Bronchopulmonary dysplasia: pathogenesis and pathophysiology","volume":"12","author":"Dankhara","year":"2023","journal-title":"J. Clin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"167309","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J. Mol. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"101384","DOI":"10.1016\/j.siny.2022.101384","article-title":"Long term outcome of babies with pulmonary hypertension","volume":"27","author":"Durward","year":"2022","journal-title":"Seminars Fetal Neonatal Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"102953","DOI":"10.1016\/j.arr.2025.102953","article-title":"The role of in silico and in vitro models in Parkinson\u2019s disease: drug discovery and therapy applications","volume":"113","author":"Himwaba","year":"2026","journal-title":"Ageing Res. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12931-024-02678-5","article-title":"Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)","volume":"25","author":"Huang","year":"2024","journal-title":"Respir. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"115025","DOI":"10.1016\/j.intimp.2025.115025","article-title":"Caspase-8-driven NLRP3 inflammasome activation exacerbates bronchopulmonary dysplasia by increasing the apoptosis and pyroptosis crosstalk of alveolar epithelial cells","volume":"161","author":"Huang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1055\/a-2821-3458","article-title":"NEC-associated bronchopulmonary dysplasia and the gut-lung axis in preterm infants","author":"Jawale","year":"2026","journal-title":"Am. J. Perinatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"10569","DOI":"10.3390\/ijms262110569","article-title":"In silico identification of the NLRP3 inhibitors from traditional Chinese medicine","volume":"26","author":"Jia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e20210125","DOI":"10.36416\/1806-3756\/e20210125","article-title":"The high-risk factors of different severities of bronchopulmonary dysplasia (BPD) based on the national institute of child health and human development (NICHD) diagnosis criteria in 2018","volume":"47","author":"Jian","year":"2021","journal-title":"J. Bras. Pneumol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1186\/s12887-025-06044-2","article-title":"Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990-2021 and predictions to 2050","volume":"25","author":"Jiang","year":"2025","journal-title":"BMC Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1006654","DOI":"10.3389\/fimmu.2022.1006654","article-title":"The NLRP3 inflammasome as a new target in respiratory disorders treatment","volume":"13","author":"Leszczy\u0144ska","year":"2022","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"32347","DOI":"10.1038\/s41598-025-14685-7","article-title":"Epidemiology and co-infection patterns of community-acquired pneumonia among children from 2015 to 2023 in Henan Province, China: longitudinal surveillance study","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.1038\/ncomms9977","article-title":"The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia","volume":"6","author":"Liao","year":"2015","journal-title":"Nat. Commun."},{"key":"B27","first-page":"13","article-title":"Predictors of bronchopulmonary dysplasia occurrence and severity in extremely preterm infants","author":"Liu","year":"2025","journal-title":"Front. Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s15010-025-02605-w","article-title":"Recent updates regarding the management and treatment of pneumonia in pediatric patients: a comprehensive review","volume":"53","author":"Ma","year":"2025","journal-title":"Infection"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16556","DOI":"10.3390\/ijms242316556","article-title":"NLRP3 inflammasome involvement in heart, liver, and lung diseases\u2014A lesson from cytokine storm syndrome","volume":"24","author":"Napodano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e71395","DOI":"10.1002\/hsr2.71395","article-title":"The burden of hospitalization due to klebsiella pneumoniae-Associated pneumonia in children under 5 years in Low- and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"Odoom","year":"2025","journal-title":"Health Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3892\/etm.2025.13045","article-title":"Development and internal validation of a clinical nomogram for predicting bronchopulmonary dysplasia in preterm infants","volume":"31","author":"Pan","year":"2026","journal-title":"Exp. Ther. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4208\/cicp.270711.140911s","article-title":"Poisson-Boltzmann Calculations: van der Waals or Molecular Surface?","volume":"13","author":"Pang","year":"2013","journal-title":"Commun. Comput. Phys."},{"key":"B33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fimmu.2025.1682649","article-title":"Role of toll-like receptors in pulmonary immunity: mechanisms and therapeutic implications","volume":"16","author":"Qu","year":"2025","journal-title":"Front. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e30898","DOI":"10.1016\/j.heliyon.2024.e30898","article-title":"Matrix Metalloproteinase\/fas ligand (MMP\/FasL) interaction dynamics in COVID-19: an in silico study and neuroimmune perspective","volume":"10","author":"Saleki","year":"2024","journal-title":"Heliyon"},{"key":"B35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5115\/acb.2012.45.4.221","article-title":"Respiratory epithelial cell lines exposed to anoxia produced inflammatory mediator","volume":"45","author":"Shahriary","year":"2012","journal-title":"Anat. Cell. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e193975","DOI":"10.1172\/jci.insight.193975","article-title":"Defining endotypes of bronchopulmonary dysplasia in preterm infants to improve precision-based therapies","volume":"10","author":"Sharma","year":"2025","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.53854\/liim-3304-8","article-title":"Burden of neonatal pneumonia and risk factors for severe disease in low - and middle - income country","volume":"33","author":"To","year":"2025","journal-title":"Infez. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/ph18030419","article-title":"Potential benefits of in silico methods: a promising alternative in natural compound\u2019s drug discovery and repurposing for HBV therapy","volume":"18","author":"Ugbaja","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijid.2020.11.168","article-title":"Current spectrum of causative pathogens in sepsis: a prospective nationwide cohort study in Japan","volume":"103","author":"Umemura","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"10905","DOI":"10.21037\/qims-2025-1216","article-title":"Effect of bronchopulmonary dysplasia and pneumonia on the neurodevelopment of preterm infants: a cerebral blood flow study","volume":"15","author":"Wang","year":"2025","journal-title":"Quant. Imaging Med. Surg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"116140","DOI":"10.1016\/j.biopha.2024.116140","article-title":"The role and therapeutic potential of nuclear factor \u03baB (NF-\u03baB) in ischemic stroke","volume":"171","author":"Xu","year":"2024","journal-title":"Biomed. and Pharmacother."},{"key":"B42","first-page":"13","article-title":"Analysis of risk factors contributing to neonatal pneumonia in low birth weight neonates","author":"Xu","year":"2025","journal-title":"Front. Pediatr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3390\/cells13242094","article-title":"Unveiling the emerging role of extracellular vesicle\u2013inflammasomes in hyperoxia-induced neonatal lung and brain injury","volume":"13","author":"Young","year":"2024","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B45","article-title":"Dexmedetomidine's protective mechanism against hyperoxic injury in neonatal rats","volume":"75","author":"Zhang","year":"2024","journal-title":"J. Physiol. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1002\/ppul.27209","article-title":"Eclipta prostrata improves alveolar development of bronchopulmonary dysplasia via suppressing the NLRP3 inflammasome in a DLD-Dependent manner","volume":"59","author":"Zheng","year":"2024","journal-title":"Pediatr. Pulmonol."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1859262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:15:28Z","timestamp":1782821728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1859262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":46,"alternative-id":["10.3389\/fchem.2026.1859262"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2026.1859262","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1859262"}}